CIRCLES DESIGN (ALMUS DESIGN) — 1353972
Application number
1353972
Type(s)
Design
Category
Trademark
CIPO Status
ABANDONED - SECTION 38(7)
TM5 status
DEAD/APPLICATION/
Withdrawn/Abandoned
The owner of the trademark application withdrew (e.g. abandoned) the application and the application is no longer active.
Filed
2007-06-29
Applicant
ALLIANCE UNICHEM IP LIMITED
2 The Heights
Brooklands, Weybridge
Surrey KT13 0NY
UNITED KINGDOM
Documents
Vienna information (Code & Description)
- 21.3.1
- Footballs and other balls, shuttlecocks
- 25.7.1
- Surfaces or backgrounds covered with repeated geometrical figures or designs
- A 25.7.6
- Surfaces or backgrounds covered with circles or ellipses
- A 25.7.7
- Surfaces or backgrounds covered with dots
- 26.1.1
- Circles
- 26.1.6
- Several circles or ellipses, juxtaposed, tangential or intersecting
- A 26.1.24
- Circles or ellipses with dark surfaces or parts of surfaces
Goods (Nice class & Statement)
- (1) Pharmaceutical preparations for use in the treatment of Crohn's Disease, Ulcerative Colitis, severe eczema, Myasthenia Gravis and transplant rejection; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for eye infection, ear infection and nose infection; pharmaceutical preparations for the treatment of the urinary tract; pharmaceutical preparations for the treatment of malignant disease being defined as Acute Lymphoblastic Leukaemia, Hodgkin's Disease, Non-Hodgkins Lymphomas; pharmaceutical preparations for use in nutrition namely for the treatment and prevention of scurvy or for the treatment of Vitamin B deficiency; immunosuppressants and immunological products, namely, products to treat autoimmune conditions, namely, Crohn's Disease, ulcerative colitis, severe eczema, Myasthenia Gravis and transplant rejection; pharmaceutical preparations for relief of pain, headache, colds and flu symptoms, neuralgia, reduction of inflammation and lowering of temperature; pharmaceutical preparations for the treatment and prevention of nasal congestion, sore throats, asthma, allergies, arthritis, mouth pain, constipation, diarrhoea, acne, dermatitis, psoriasis, fungal infection, cold sores, sleep disturbance, ear wax, haemorrhoids and to assist in the cessation of smoking; pharmaceuticals with anti-inflammatory, anti-rheumatic, anti-pyretic and analgesic properties, namely, Acetylsalicylic Acid, Co-Codamol, Codeine Phosphate, Diclofenac, Digoxin, Ibuprofen, Indometacin, Ketoprofen, Mefenamic Acid, Meloxicam, Nabumetone, Naproxen, Paracetamol, Piroxicam, Prednisolone, Sulfasalazine, Tramadol; antibiotics; dietary supplements, namely vitamins; Ascorbic acid tablets for use in treating Vitamin C deficiency including the treatment and prevention of scurvy; calcium ergocalciferol tablets for the treatment of nutritional deficiency in Vitamin D including nutritional rickets; ferrous sulphate tablets for the prevention and treatment of iron-deficiency anaemia; folic acid for the normal production and maturation of blood cells and for the treatment of nutritional megaloblastic anaemia; thiamine for Vitamin B1 supplement; Vitamin B compound strong tablets for the treatment of clinical and sub-clinical Vitamin B deficiency states such as manifestations including glassitis, stomatitis, cheilosis, heart manifestations of beriberi, skin manifestations of pellagra, corneal vascularisation and polyneuritis; medicated herbal tea; nutritional meal replacement or meal supplement drink mix consisting of vitamins, minerals, protein and skim milk; dermatological products, namely Aqueous cream BP; Clotrimazole cream 1% BP for the treatment of skin infections due to dermatophytes (trycophyton species), yeast (candida species), moulds and other fungi; emulsifying ointment; hydrous ointment; pharmaceutical preparations to treat the gastrointestinal system, the central nervous system, infection, the endocrine system, blood, musculoskeletal and joint disease, and oropharynx skin and malignant disease, and other oncological diseases, namely, Acebutolol, Acetylcysteine, Aciclovir, Alendronic Acid, Allopurinol, Alprazolam, Amiloride, Amisulpride, Amitriptyline, Amlodipine, Amoxicillin, Aqueous Cream, Ascorbic Acid, Acetylsalicylic Acid, Atenolol, Azathioprine, Baclofen, Beclometasone, Bendroflumethiazide, Betahistine, Bicalutamide, Bisacodyl, Budesonide, Bumetanide, Calcium Ergocalciferol, Carbocisteine, Cefixime, Cefpodoxime, Ceftazidime, Ceftriaxone, Cefuroxime, Cetirizine Hydrochloride, Chloramphenicol, Chlorpheniramine, Chlorpromazine, Cimetidine, Ciprofloxacin, Citalopram, Clarithromycin, Clobazam, Clonazepam, Clotrimazole, Co-Amoxiclav, Co-Codamol, Co-Cyprindiol, Codeine phosphate, Co-Dydramol, Co-Fluampicillin, Co-Trimoxazole, Cyproterone Acetate, Deflazacorte, Dexamethasone, Diazepam, Diclofenac, Dihydrocodeine, Domperidone, Donepezil, Dosulepin, Doxycycline, Emulsifying Ointment, Erythromycin, Ferrous Sulphate, Finasteride, Flucloxacillin, Fluconazole, Flunisolide, Fluoxetine, Folic Acid, Furosemide, Gabapentin, Gliclazide, Glimepiride, Hydrocortisone, Hyoscine, Hypromellose, Ibuprofen, Imipramine, Indometacin, Ipratropium, Ketoprofen, Ketotifen, Lamotigine, Lansoprazole, Levofloxacin, Levothyroxine, Lofepramine, Loperamide, Lorazepam, Lormetazepam, Mefanamic Acid, Meloxicam, Metformin, Methyl Dopa, Metoclopramide, Metronidazole, Mianserin, Minocycline, Mirtazapine, Nabumetone, Naproxen, Nitrazepam, Nizatidine, Omeprazole, Ondansetron, Oxybutynin, Oxytetracycline, Pantoprazole, Paracetemol, Paroxetine, Phenoxymethylpenicillin, Pilocarpine, Piroxicam, Pizotifen, Prednisolone, Prochlorperazine, Procyclidine, Quinine Sulphate, Ranitide, Repagalinide, Risperidone, Salbutamol, Saline Nasal, Senna, Sertraline, Sodium Bicarbonate, Sulfasalazine, Sumatriptan, Tamsulosin, Terbinafine, Tetracycline, Tetrazepam, Thiamine, Timolol Maleate, Tolbutamide, Tolnafate, Topiramate, Tramadol, Trimebutine, Trimethoprim, Valaciclovir, Venlafaxine, Vitamin B Co Strong, Warfarin, Zopiclone.
Services (Nice class & Statement)
(1) Advisory and consultation services in the field of pharmaceutical and veterinary preparations; advisory and consultation services relating to medical conditions and diseases and the treatment thereof.
Classification data
Disclaimer
The classification data is provided for information and searching purposes only. CIPO does not warrant the accuracy of the classes assigned to the trademark. This data has no legal value of any kind.
- 5 - Pharmaceuticals and herbicides
- 44 - Medical and veterinary, beauty, agricultural and forestry
Claims
- Proposed Use in CANADA
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2007-06-29 | ||
| Created | 2007-06-29 | ||
| Formalized | 2007-07-05 | ||
| Search Recorded | 2007-12-11 | ||
| Examiner's First Report | 2007-12-11 | 2008-04-11 | |
| Extension of Time | 2008-04-17 | 2008-10-11 | Request Letter Date: 2008/04/08 |
| Extension of Time | 2008-10-28 | 2009-04-11 | Request Letter Date: 2008/10/08 |
| Correspondence Created | 2009-03-30 | 2009-07-30 | |
| Approval Notice Sent | 2009-04-22 | 2009-05-20 | |
| Approved | 2009-06-11 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2009-07-08 | Vol.56 Issue 2854 | |
| Opposed | 2009-07-27 | Opposition Filed by receiving mail. | |
| Abandoned - Section 38 Opposition | 2010-01-08 | Deemed abandoned by Trade-marks Opposition Board |
Opposition History
Case # 1 : Huvepharma JSC - Deemed Abandoned
| Action | Action date | Due date |
|---|---|---|
| Case Closed - Abandoned Section 38(7) | 2010-01-08 |
Statement of Opposition
| Action | Action date | Due date |
|---|---|---|
| S/O Fee Received | 2009-07-22 | |
| S/O Filed | 2009-07-22 | |
| S/O Forwarded for Review | 2009-08-12 | |
| S/O Sent to Applicant | 2009-08-27 | 2009-10-27 |
Counter Statement
| Action | Action date | Due date |
|---|---|---|
| Failed to File C/S | 2009-11-30 | 2009-12-30 |